BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park IH, Kim SY, Kim YW, Ryu KW, Lee JH, Lee JS, Park YI, Kim NK, Park SR. Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement. Cancer Chemother Pharmacol. 2011;67:127-136. [PMID: 20221601 DOI: 10.1007/s00280-010-1296-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Ito S, Ito Y, Misawa K, Shimizu Y, Kinoshita T. Neoadjuvant chemotherapy followed by surgery in gastric cancer patients with extensive lymph node metastasis. World J Clin Oncol 2015; 6(6): 291-294 [PMID: 26677442 DOI: 10.5306/wjco.v6.i6.291] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Ito S, Sano T, Mizusawa J, Takahari D, Katayama H, Katai H, Kawashima Y, Kinoshita T, Terashima M, Nashimoto A, Nakamori M, Onaya H, Sasako M. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. Gastric Cancer. 2017;20:322-331. [PMID: 27299887 DOI: 10.1007/s10120-016-0619-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 8.7] [Reference Citation Analysis]
3 Kang YK, Ryu MH, Yoo C, Chang HM, Yook JH, Oh ST, Kim BS, Kim TW. Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2011;67:1435-1443. [PMID: 20811894 DOI: 10.1007/s00280-010-1444-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
4 Fiorillo C, Laterza V, Quero G, Menghi R, Cina C, Rosa F, Tortorelli AP, Boskoski I, Alfieri S. From biology to surgery: One step beyond histology for tailored surgical treatments of gastric cancer. Surg Oncol 2020;34:86-95. [PMID: 32891359 DOI: 10.1016/j.suronc.2020.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kinoshita J, Yamaguchi T, Moriyama H, Fushida S. Current status of conversion surgery for stage IV gastric cancer. Surg Today 2021. [PMID: 33486610 DOI: 10.1007/s00595-020-02222-0] [Reference Citation Analysis]
6 Zhang F, Huang X, Song Y, Gao P, Zhou C, Guo Z, Shi J, Wu Z, Wang Z. Conversion Surgery for Stage IV Gastric Cancer. Front Oncol 2019;9:1158. [PMID: 31788445 DOI: 10.3389/fonc.2019.01158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
7 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1-19. [PMID: 27342689 DOI: 10.1007/s10120-016-0622-4] [Cited by in Crossref: 1265] [Cited by in F6Publishing: 1149] [Article Influence: 210.8] [Reference Citation Analysis]
8 Ke B, Liang H. Current status of lymph node dissection in gastric cancer. Chin J Cancer Res 2021;33:193-202. [PMID: 34158739 DOI: 10.21147/j.issn.1000-9604.2021.02.07] [Reference Citation Analysis]
9 Zheng XH, Zhang W, Yang L, Du CX, Li N, Xing GS, Tian YT, Xie YB. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis. World J Gastroenterol 2019; 25(19): 2338-2353 [PMID: 31148905 DOI: 10.3748/wjg.v25.i19.2338] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Salem A, Hashem S, Mula-Hussain LY, Mohammed I, Nour A, Shelpai W, Daoud F, Morcos B, Yamin Y, Jaradat I, Khader J, Almousa A. Management strategies for locoregional recurrence in early-stage gastric cancer: retrospective analysis and comprehensive literature review. J Gastrointest Cancer 2012;43:77-82. [PMID: 20835925 DOI: 10.1007/s12029-010-9207-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
11 Wang Y, Yu YY, Li W, Feng Y, Hou J, Ji Y, Sun YH, Shen KT, Shen ZB, Qin XY, Liu TS. A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemother Pharmacol. 2014;73:1155-1161. [PMID: 24748418 DOI: 10.1007/s00280-014-2449-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
12 Tsutsuyama M, Ito S, Ito Y, Misawa K, Kawakami J, Natsume S, Uemura N, Kinoshita T, Kimura K, Senda Y, Abe T, Komori K, Yatabe Y, Niwa Y, Shimizu Y, Kinoshita T. A Case of Gastric Cancer with Residual Tumor Only in the Para-Aortic Lymph Nodes after Systemic Chemotherapy followed by Conversion Surgery. Case Rep Oncol 2015;8:312-22. [PMID: 26351440 DOI: 10.1159/000438698] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Zhang X, Huang H, Wei Z, Zhu Z, Yang D, Fu H, Xu J, Hu Z, Zhang Y, You Q, Huang X, Yan R, Wang W, Cai Q. Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis. Cancer Manag Res 2020;12:6641-53. [PMID: 32801898 DOI: 10.2147/CMAR.S258360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mengardo V, Bencivenga M, Weindelmayer J, Pavarana M, Giacopuzzi S, de Manzoni G. Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives. Updates Surg 2018;70:207-11. [PMID: 29846892 DOI: 10.1007/s13304-018-0549-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
15 Liu T, Sun Y, Wang Y. Gastric cancer with para-aortic lymph nodes metastasis: curable dissection possible but be cautiously selected. Cancer Chemother Pharmacol 2014;74:435-6. [PMID: 25023488 DOI: 10.1007/s00280-014-2512-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Kodera Y, Kobayashi D, Tanaka C, Fujiwara M. Gastric adenocarcinoma with para-aortic lymph node metastasis: A borderline resectable cancer? Surg Today. 2015;45:1082-1090. [PMID: 25366353 DOI: 10.1007/s00595-014-1067-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
17 Takahari D, Ito S, Mizusawa J, Katayama H, Terashima M, Sasako M, Morita S, Nomura T, Yamada M, Fujiwara Y, Kimura Y, Ikeda A, Kadokawa Y, Sano T;  Stomach Cancer Study Group of the Japan Clinical Oncology Group. Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002). Gastric Cancer. 2020;23:293-299. [PMID: 31515693 DOI: 10.1007/s10120-019-01007-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
18 Dong YP, Deng JY. Advances in para-aortic nodal dissection in gastric cancer surgery: A review of research progress over the last decade. World J Clin Cases 2020; 8(13): 2703-2716 [PMID: 32742981 DOI: 10.12998/wjcc.v8.i13.2703] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hayata K, Ojima T, Nakamura M, Kitadani J, Takeuchi A, Yamaue H. Curative para-Aortic lymph node dissection Via INfra-mesocolonic approach in laparoscopic Gastrectomy (CAVING approach). Langenbecks Arch Surg 2021. [PMID: 34018040 DOI: 10.1007/s00423-021-02198-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Son SY, Lee CM, Lee JH, Ahn SH, Kim JW, Lee KU, Park do J, Kim HH. Laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after palliative chemotherapy for advanced gastric cancer with isolated para-aortic lymph node metastasis. J Korean Surg Soc. 2013;84:304-308. [PMID: 23646317 DOI: 10.4174/jkss.2013.84.5.304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]